Explore Our Publications
Entrada’s commitment to publications & transparency
Entrada is committed to publishing the results of our sponsored research in a transparent, scientifically accurate, and timely manner. Entrada will apply high ethical standards to our publications and presentations and will adhere to recognized industry guidance such as International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals and International Society for Medical Publication Professionals (ISMPP) Good Publication Practice for Communicating Company Sponsored Medical Research.
Past Presentations
-
Endosomal Escape Vehicle-Oligonucleotide Conjugates For The Targeted Upregulation And Downregulation Of Gene Expression
- By: Leo Ziqing Qian, PhD, Co-Founder & Vice President, Discovery Research, Entrada Therapeutics
- At: 2nd @Philly Cell and Gene Therapy Annual Conference
- On: June 24, 2023
DownloadJune 24, 2023 -
Endosomal Escape Vehicle-Oligonucleotide Conjugates For The Targeted Upregulation And Downregulation Of Gene Expression
- By: Ashweta Sahni, PhD, Scientist, Entrada Therapeutics
- At: 28th American Peptide Symposium
- On: June 24, 2023
DownloadJune 24, 2023 -
Endosomal Escape Vehicle-Oligonucleotide Conjugates For The Targeted Upregulation And Downregulation Of Gene Expression
- By: Mahboubeh Kheirabadi, PhD, Director, Discovery Chemistry, Entrada Therapeutics
- At: RNA Therapeutics & Delivery US 2023
- On: June 9, 2023
DownloadJune 9, 2023 -
Endosomal Escape Vehicle-Oligonucleotide Conjugates for the Targeted Upregulation and Downregulation of Gene Expression
- By: Mahboubeh Kheirabadi, PhD, Director, Discovery Chemistry, Entrada Therapeutics
- At: American Society of Cell & Gene Therapy (ASGCT) 26th Annual Conference
- On: May 16, 2023
DownloadMay 16, 2023 -
Exon Skipping and Dystrophin Production with ENTR-601-45, a Novel EEV-Conjugated, Exon 45 Skip Amenable PMO in Preclinical Models of DMD
- By: Xiang Li, PhD, Associate Director, Discovery Research, Entrada Therapeutics
- At: American Society of Cell & Gene Therapy (ASGCT) 26th Annual Conference
- On: May 16, 2023
DownloadMay 16, 2023 -
American Society of Cell & Gene Therapy (ASGCT) 26th Annual Conference
- By: Nerissa Kreher, MD, Chief Medical Officer, Entrada Therapeutics
- At: CureDuchenne FUTURES 2023 National Conference
- On: April 21, 2023
DownloadApril 21, 2023